Biodesix
BDSX
46 hedge funds and large institutions have $7.06M invested in Biodesix in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 5 closing their positions.
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
12% more funds holding
Funds holding: 41 → 46 (+5)
0.08% less ownership
Funds ownership: 0.75% → 0.67% (-0.08%)
6% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 16
67% less capital invested
Capital invested by funds: $21.4M → $7.06M (-$14.3M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$1.77M |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$427K |
| 3 |
Millennium Management
New York
|
+$295K |
| 4 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$90.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$60.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$2.1M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$510K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$104K |
| 4 |
JP Morgan Chase
New York
|
-$101K |
| 5 |
PP
PDT Partners
New York
|
-$91K |
BDSX Hedge Fund Activity: Q1 2022 in Review
46 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Biodesix (BDSX) for Q1 2022, worth a combined $7.06M — down 67% from $21.4M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new BDSX positions and 5 closed out — a net gain of 5 holders — while 15 added to existing stakes and 16 trimmed.
The largest buyer was Wells Fargo, adding an estimated $1.77M. The largest seller was Parian Global Management, exiting entirely with an estimated $2.1M sold.
- 46 institutional investors held Biodesix (BDSX) as of Q1 2022, up from 41 in Q4 2021.
- Funds reported $7.06M of Biodesix stock for Q1 2022, down 67% quarter-over-quarter.
- 10 funds opened new Biodesix positions in Q1 2022 and 5 closed out, a net change of +5 holders.
- The largest Biodesix buyer in Q1 2022 was Wells Fargo, an estimated $1.77M added.
- The largest Biodesix seller in Q1 2022 was Parian Global Management, an estimated $2.1M sold.
Based on aggregated 13F filings for Q1 2022.